Implementing VistA Internationally:
Myth-Busting Lessons From Jordan



Nuffield Trust, London
July 5, 2012


Joseph Dal Molin
President, e-cology corporation
Chairman, WorldVistA




                                  1
                             1
Agenda



   Background and Context
   Why VistA
   Jordan's Leapfrog Approach
   Achievements




                             2   2
Background and Context




                         3
          3
Jordan's Health System


 Population   6 million
 46+   Hospitals, 800+ Clinics
 Ministry   of Health
 Royal   Medical Services
 University   Hospitals
 King   Hussein Cancer Centre




                                          4
                                  4
Jordan's Health System Challenges


 Significant   concerns about patient safety and health outcomes
 Significant   waste (drugs, tests, imaging) across the system
 Spiralling   cost drivers e.g. chronic disease
 Impossible to share medical information and provide clinical
  decision support
 Difficult
          to impossible to measure clinical effectiveness and
  ROI of health policies and investment




                                 5                           5
Why VistA?




             6
    6
Chronic Failure of Traditional Health IT
                     Approaches


    Existing
            ICT solutions could not support transformation via
     implementation of evidence based, best practices
    Proprietary    solutions too expensive to implement
    Lock-in

    Sustainability   > capacity building, code stewardship
    Pitfalls   experienced in other countries: UK, Canada, US


    There was compelling evidence that the US Veterans
Administration and VistA stood out as positive example of how
                 to successfully leverage IT




                                   7                             7
VA Top Performer:
        VistA Enables Dramatically Lower Costs


The cost per patient has
remained low and stayed
steady for the VA since
the system went digital.
By comparison, costs for
Medicare patients and
the medical consumer
price index have
remained high and are
increasing.

SOURCE: The Washington
Post, April 10, 2007



                           8                     8
VA Top Clinical Performance


                                            VA         VA    COMMERCIAL    MEDICARE   MEDICAID
INDICATOR                                  2009       2008      2008         2008       2008
Breast Cancer Screening                    87%        87%       70%          68%        51%
Cervical Cancer Screening                  92%        92%       80%           n/a       66%
Colorectal Cancer Screening                80%        79%       59%          53%         n/a
LDL Cholesterol <100 after AMI,PTCA,CABG   67%        66%       60%          57%        40%
Diabetes: CM control HbA1c < 9.0%          98%        97%       89%          88%        81%
Diabetes: LDL-C<100                        69%        68%       46%          49%        34%
Diabetes: eye Exam                         88%        86%       57%          61%        53%
Diabetes: Renal Exam                       95%        93%       82%          88%        77%
Diabets: BP < 140/90                       80%        78%       66%          60%        57%
Smoking Cessation Counseling               96%        89%       77%           n/a       69%
Smoking: Medications Offered               90%        84%       54%           n/a       41%
Smoling: Referral/Strategies               96%        92%       50%           n/a       41%
Immunizations: Influenza                   83%        84%        n/a         71%         n/a
Immunizations: Pneumococcal                95%        94%        n/a         67%         n/a




                                                                          Source: VHA, 2009



                                                  9                                   9
Model for Radical Transformation:
Transition to More Effective Care Settings




          Source: Perlin et al., 2004, American Journal of Managed Care
                          10                                   10
VistA Has Produced a Huge ROI: $3.09 billion




The potential value of the VA’s health IT investments is estimated at
$3.09 billion in cumulative benefits NET of investment costs.
                             Source: Health Affairs 29, NO. 4 (2010): 629–638
                              11                                     11
VistA Can Scale!


                        File Entries Dec '09        Daily File Entry Dec '09

Orders                  2.30 billion                1,23 million
Images                  1.40 billion                1.70 million
TIU Documents           1.35 billion                952 thousand
Medication Admin        1.24 billion                708 thousand
Vital Signs             1,56 billion                977 thousand


                   Source: Dr. Ross Fletcher, Chief of Staff, Washington DC VAMC




                                       12                                12
Jordan's Leapfrog Approach




                             13
            13
Leapfrog over this




                     Photo credit: www.ericmackonline.com

        14                                  14
.....to this




               Photo credit: Wikipedia   15
     15
...and iterate to this




                  Photo credit: Marianna Day Massey, Zuma Press
          16                                    16
Critical Questions to Address



 Can   it be adapted?
 Will it be accepted by clinical staff?
 Can we learn how to enhance it?
 Can we build capacity to reduce cost and risk?
 Can we afford it and will it cost less than comparable
  approaches?
 Will it work?




                              17                           17
Iterative Implementation Model



 Assessment     Phase
 First Iteration National Implementation Strategy
 Pilot Site Selection
 Establish Public Sector Non-Profit
 Proof of Concept
 Seed Site Implementation
 Evaluation
 Second Iteration National Implementation Strategy




                             18                       18
Technology Strategy



 FollowVA development standards
 Minimal (Minspec) changes to WorldVistA EHR
   – Arab language support for Registration, Medication Labels,
       Patient information
   – Registration gui
   – Scheduling gui
 Test centralized and decentralized architecture
 Collaborate with community




                              19                              19
Benefits of Phased Implementation Approach


 Establish local capacity and sustainability in parallel to seed
  site implementation
 Minimum specifications for customization and adaptation
 Implementation path is bottom up, evolutionary and guided by
  learning
 Create contagious buy-in and support
 Early validation of clinical and financial business case




                              20                            20
Asessment = Road Trip




                        21
          21
Assessing the Health Ecosystem




                                 22
              22
What We Found:
                High Leverage Opportunities

The following areas represented up to 30% annual “hard” cost
savings which in total have the potential to fund national
deployment of WorldVistA EHR.
Medication    management – stop polypharmacy
   Estimated savings 30 – 50 m JD per year
   Clinical benefits of avoiding errors and interactions
   Better data for purchasing decisions – id. Substitutes and cost
    savings
Imaging
   Cost of PACS software savings
   Cost of film savings
   Telemedicine support – savings through remote consultation
Laboratory
     Avoid duplication of tests



                                   23                                 23
What We Found:
        Business Process Transformation

 Supply  chain – drugs, other consumables availability
 Unit dose packaging
 Standardized bar coding of medications
 Electronic signature
 Controlled substances
 Integration with national unique identifier database
 Alignment of roles and responsibilities, e.g. nurses and
  nursing assistants with best practices




                              24                             24
Scope of Implementation




 National   roll-out to 46 hospitals and 1000 clinics

 Pilot   Sites
    – King Hussein Cancer Centre
    – Prince Hamzah Hospital (MoH)
    – Amman Comprehensive Clinic




                                25                       25
Selected WorldVistA EHR


 Deliverable   of HHS/CMS funded VistA Office EHR initiative
 Certified
    – CCHIT certified 2007
    – Meaningful Use Full Inpatient and Ambulatory Certification, 2011
 Enhancements
      Pediatrics – growth charts, demographics
      Women's health
      Registration
      E-Prescribing
      CCR/CCD export and import
      HTML 5 web interface
 Implementations    – Jordan, Mexico, US hospitals and primary
 care


                                26                              26
Achievements




               27
     27
Achievements:
        Affordable, Sustainable, It Works!


 Established a new, health stakeholder run, non-profit
 Established 98% self-reliance in 18 months
 Successful adaptation and configuration
 Confirmed affordability
 Successful go-live of full implementation, including imaging
  and bar code medication administration in late Fall 2011
 Given green light for national implementation




                              28                            28
Achievements:
      Community Based, Rapid, Open Innovation



Collaborative Successes
     IHS Graphical scheduling interface
     WHO standard based pediatric growth charts
     EDIS – emergency room package
     Support for internationalization


Current Innovations
     Web enabling of VistA – EWD and HTML5
     Harvard SMART program – “App” development platform




                               29                          29
Achievement: Patient Number One




               30                 30
Thank You!




             31
    31
WorldVistA and the VistA Community


 Incorporated  in 2002 as 501c 3
 Established the open source VistA community
 Ported VistA to full open source software stack: Linux + GT.M
 2005 CMS funded VistA Office EHR initiative
 2007 CCHIT and 2011 Full Inpatient and Ambulatory
  Meaningful Use Certification
 2007 Jordan adopts WorldVistA EHR for national deployment
 2007 Wired Magazine Rave Award for Medicine




                                                           32
                             32
International Deployments


 WorldVistA     EHR
     Jordan – 2 live, planned 44 inpatient, 800 ambulatory
     Mexico - Instituto Mexicano del Seguro Social (50+ hospitals)
     Thailand – Queen Sirikit Medical Center Cardiovascular Clinic
     India – Rajiv Ghandi Cancer Center, Max Health, hospital
      network
 FOIA   VistA
     American Samoa (FOIA)
     Egypt, Cairo - National Cancer Institute (FOIA)
     Uganda, Kampala - Nakasero Blood Bank (FOIA)
     Nigeria - Obafemi Awolowo University and eight (8) Teaching
      Hospitals (FOIA)
     Pakistan - SKM Cancer Hospital and Research Centre (FOIA)




                               33                              33

Joseph Dal Molin: Implementing VistA internationally: Myth-busting lessons from Jordan

  • 1.
    Implementing VistA Internationally: Myth-BustingLessons From Jordan Nuffield Trust, London July 5, 2012 Joseph Dal Molin President, e-cology corporation Chairman, WorldVistA 1 1
  • 2.
    Agenda  Background and Context  Why VistA  Jordan's Leapfrog Approach  Achievements 2 2
  • 3.
  • 4.
    Jordan's Health System Population 6 million  46+ Hospitals, 800+ Clinics  Ministry of Health  Royal Medical Services  University Hospitals  King Hussein Cancer Centre 4 4
  • 5.
    Jordan's Health SystemChallenges  Significant concerns about patient safety and health outcomes  Significant waste (drugs, tests, imaging) across the system  Spiralling cost drivers e.g. chronic disease  Impossible to share medical information and provide clinical decision support  Difficult to impossible to measure clinical effectiveness and ROI of health policies and investment 5 5
  • 6.
  • 7.
    Chronic Failure ofTraditional Health IT Approaches  Existing ICT solutions could not support transformation via implementation of evidence based, best practices  Proprietary solutions too expensive to implement  Lock-in  Sustainability > capacity building, code stewardship  Pitfalls experienced in other countries: UK, Canada, US There was compelling evidence that the US Veterans Administration and VistA stood out as positive example of how to successfully leverage IT 7 7
  • 8.
    VA Top Performer: VistA Enables Dramatically Lower Costs The cost per patient has remained low and stayed steady for the VA since the system went digital. By comparison, costs for Medicare patients and the medical consumer price index have remained high and are increasing. SOURCE: The Washington Post, April 10, 2007 8 8
  • 9.
    VA Top ClinicalPerformance VA VA COMMERCIAL MEDICARE MEDICAID INDICATOR 2009 2008 2008 2008 2008 Breast Cancer Screening 87% 87% 70% 68% 51% Cervical Cancer Screening 92% 92% 80% n/a 66% Colorectal Cancer Screening 80% 79% 59% 53% n/a LDL Cholesterol <100 after AMI,PTCA,CABG 67% 66% 60% 57% 40% Diabetes: CM control HbA1c < 9.0% 98% 97% 89% 88% 81% Diabetes: LDL-C<100 69% 68% 46% 49% 34% Diabetes: eye Exam 88% 86% 57% 61% 53% Diabetes: Renal Exam 95% 93% 82% 88% 77% Diabets: BP < 140/90 80% 78% 66% 60% 57% Smoking Cessation Counseling 96% 89% 77% n/a 69% Smoking: Medications Offered 90% 84% 54% n/a 41% Smoling: Referral/Strategies 96% 92% 50% n/a 41% Immunizations: Influenza 83% 84% n/a 71% n/a Immunizations: Pneumococcal 95% 94% n/a 67% n/a Source: VHA, 2009 9 9
  • 10.
    Model for RadicalTransformation: Transition to More Effective Care Settings Source: Perlin et al., 2004, American Journal of Managed Care 10 10
  • 11.
    VistA Has Produceda Huge ROI: $3.09 billion The potential value of the VA’s health IT investments is estimated at $3.09 billion in cumulative benefits NET of investment costs. Source: Health Affairs 29, NO. 4 (2010): 629–638 11 11
  • 12.
    VistA Can Scale! File Entries Dec '09 Daily File Entry Dec '09 Orders 2.30 billion 1,23 million Images 1.40 billion 1.70 million TIU Documents 1.35 billion 952 thousand Medication Admin 1.24 billion 708 thousand Vital Signs 1,56 billion 977 thousand Source: Dr. Ross Fletcher, Chief of Staff, Washington DC VAMC 12 12
  • 13.
  • 14.
    Leapfrog over this Photo credit: www.ericmackonline.com 14 14
  • 15.
    .....to this Photo credit: Wikipedia 15 15
  • 16.
    ...and iterate tothis Photo credit: Marianna Day Massey, Zuma Press 16 16
  • 17.
    Critical Questions toAddress  Can it be adapted?  Will it be accepted by clinical staff?  Can we learn how to enhance it?  Can we build capacity to reduce cost and risk?  Can we afford it and will it cost less than comparable approaches?  Will it work? 17 17
  • 18.
    Iterative Implementation Model Assessment Phase  First Iteration National Implementation Strategy  Pilot Site Selection  Establish Public Sector Non-Profit  Proof of Concept  Seed Site Implementation  Evaluation  Second Iteration National Implementation Strategy 18 18
  • 19.
    Technology Strategy  FollowVAdevelopment standards  Minimal (Minspec) changes to WorldVistA EHR – Arab language support for Registration, Medication Labels, Patient information – Registration gui – Scheduling gui  Test centralized and decentralized architecture  Collaborate with community 19 19
  • 20.
    Benefits of PhasedImplementation Approach  Establish local capacity and sustainability in parallel to seed site implementation  Minimum specifications for customization and adaptation  Implementation path is bottom up, evolutionary and guided by learning  Create contagious buy-in and support  Early validation of clinical and financial business case 20 20
  • 21.
    Asessment = RoadTrip 21 21
  • 22.
    Assessing the HealthEcosystem 22 22
  • 23.
    What We Found: High Leverage Opportunities The following areas represented up to 30% annual “hard” cost savings which in total have the potential to fund national deployment of WorldVistA EHR. Medication management – stop polypharmacy  Estimated savings 30 – 50 m JD per year  Clinical benefits of avoiding errors and interactions  Better data for purchasing decisions – id. Substitutes and cost savings Imaging  Cost of PACS software savings  Cost of film savings  Telemedicine support – savings through remote consultation Laboratory  Avoid duplication of tests 23 23
  • 24.
    What We Found: Business Process Transformation  Supply chain – drugs, other consumables availability  Unit dose packaging  Standardized bar coding of medications  Electronic signature  Controlled substances  Integration with national unique identifier database  Alignment of roles and responsibilities, e.g. nurses and nursing assistants with best practices 24 24
  • 25.
    Scope of Implementation National roll-out to 46 hospitals and 1000 clinics  Pilot Sites – King Hussein Cancer Centre – Prince Hamzah Hospital (MoH) – Amman Comprehensive Clinic 25 25
  • 26.
    Selected WorldVistA EHR Deliverable of HHS/CMS funded VistA Office EHR initiative  Certified – CCHIT certified 2007 – Meaningful Use Full Inpatient and Ambulatory Certification, 2011  Enhancements  Pediatrics – growth charts, demographics  Women's health  Registration  E-Prescribing  CCR/CCD export and import  HTML 5 web interface  Implementations – Jordan, Mexico, US hospitals and primary care 26 26
  • 27.
  • 28.
    Achievements: Affordable, Sustainable, It Works!  Established a new, health stakeholder run, non-profit  Established 98% self-reliance in 18 months  Successful adaptation and configuration  Confirmed affordability  Successful go-live of full implementation, including imaging and bar code medication administration in late Fall 2011  Given green light for national implementation 28 28
  • 29.
    Achievements: Community Based, Rapid, Open Innovation Collaborative Successes  IHS Graphical scheduling interface  WHO standard based pediatric growth charts  EDIS – emergency room package  Support for internationalization Current Innovations  Web enabling of VistA – EWD and HTML5  Harvard SMART program – “App” development platform 29 29
  • 30.
  • 31.
  • 32.
    WorldVistA and theVistA Community  Incorporated in 2002 as 501c 3  Established the open source VistA community  Ported VistA to full open source software stack: Linux + GT.M  2005 CMS funded VistA Office EHR initiative  2007 CCHIT and 2011 Full Inpatient and Ambulatory Meaningful Use Certification  2007 Jordan adopts WorldVistA EHR for national deployment  2007 Wired Magazine Rave Award for Medicine 32 32
  • 33.
    International Deployments  WorldVistA EHR  Jordan – 2 live, planned 44 inpatient, 800 ambulatory  Mexico - Instituto Mexicano del Seguro Social (50+ hospitals)  Thailand – Queen Sirikit Medical Center Cardiovascular Clinic  India – Rajiv Ghandi Cancer Center, Max Health, hospital network  FOIA VistA  American Samoa (FOIA)  Egypt, Cairo - National Cancer Institute (FOIA)  Uganda, Kampala - Nakasero Blood Bank (FOIA)  Nigeria - Obafemi Awolowo University and eight (8) Teaching Hospitals (FOIA)  Pakistan - SKM Cancer Hospital and Research Centre (FOIA) 33 33